Adcetris is an antibody-drug conjugate that combines an antibody and drug, allowing the antibody to direct the drug to a target on lymphoma cells known as CD30.
Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, is approved by the US Food and Drug Administration for metastatic colon cancer.
由美国食品与药品管理局批准治疗转移克隆癌的贝伐单抗，是血管内皮生长因子的单克隆抗体。
3
Elan also has an antibody-based drug in clinical trials.